12月22日，华芢生物科技(青岛)股份有限公司（以下简称“华芢生物”2396.HK)在港交所敲钟。华芢生物成为青岛第86家上市公司，也是今年继泰凯英之后第二家新上市公司，为2025年青岛资本市场工作画上圆满句号。此前，总部位于青岛市南区的创新药企业思路迪医药（1244.HK）于2022年12月登陆港交所，华芢生物成为思路迪医药之后青岛第二家创新药上市公司。华芢生物发售价定为38.20港元/股，本次...
Source Link12月22日，华芢生物科技(青岛)股份有限公司（以下简称“华芢生物”2396.HK)在港交所敲钟。华芢生物成为青岛第86家上市公司，也是今年继泰凯英之后第二家新上市公司，为2025年青岛资本市场工作画上圆满句号。此前，总部位于青岛市南区的创新药企业思路迪医药（1244.HK）于2022年12月登陆港交所，华芢生物成为思路迪医药之后青岛第二家创新药上市公司。华芢生物发售价定为38.20港元/股，本次...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.